RefinedPractice
Reminder: Risk Sharing Master Class
3 June 2010
On 29 June, OHE will collaborate with the Pope Woodhead consultancy to present a workshop on implementing risk sharing and patient access schemes within a market…
Biosimilars: Issues Overview
1 June 2010
This is the second in our series of posts based on the OHE seminar on biosimilars and summarises the remarks of Prof Bengt Jönsson of the…
2010 Lecture: US Health Care Reform
27 May 2010
OHE’s 2010 Annual Lecture features Dr Alan Garber on the implications of the American health care reform law. Register to join us in London on 22…
The Impact of Biosimilars on Markets
24 May 2010
The availability of biosimilars — ‘copies’ of biologics — is very recent and limited so far to only a few products. Projecting the impact on markets…
HTAinSite: The NICE Decision Database
18 May 2010
HTAinSite is a unique resource that enables subscribers to quickly find relevant information on NICE technology appraisal (TA) decisions and the evidence used to support them.…
Workshop on HTA and Regulatory Review
13 May 2010
Tensions between broad access to new medical technologies and efforts to contain health care costs are perennial. In recent years, this has become evident in the…
Risk Sharing & Patient Access Schemes Workshop
10 May 2010
On 29 June, OHE will collaborate with the Pope Woodhead consultancy to present a workshop on implementing risk sharing and patient access schemes within a market…
OHE’s Mestre-Ferrandiz has new appointment
4 May 2010
OHE is delighted to announce that Dr Jorge Mestre-Ferrandiz has been appointed an Honorary Visiting Lecturer in the Department of Economics at City University London.
Time Trade Off and Valuing Quality of Life
28 April 2010
In an article in Health Economics, Prof Devlin and her co-authors demonstrate the promise of using Lead Time TTO to value health ‘state worse than death’.…